People Talking @ Cutting Edge Festival
Torbjørn Røe Isaksen (Minister of Trade and Industry )
Ane Aanesland (ThrustMe)
Ane Aanesland is a recognised expert in plasma physics and electric propulsion. She is the author of 60+ refereed journal papers, inventor of 4 patents, and has over 100 conferences contributions including 25 invited talks at prestigious international conferences.
Ane started her career at the northernmost university in the world, The Arctic University of Norway, where she obtained a PhD in Plasma Physics. She then worked as a researcher at the Australian National University in Australia for three years, before she came to France in 2006. She entered the CNRS in 2008 and was responsible for research on innovative electric propulsion at the Ecole Polytechnique. She later headed a 30 people research group in the Laboratory of Plasma physics, and was nominated director of research at the CNRS in 2017.
She is now on leave from the CNRS and together with her colleague Dmytro Rafalskyi, she funded the startup ThrustMe in February of 2017, where she is the president and CEO. ThrustMe is now 15 people and they raised 4.6 M€ in private equity and governmental grants over the last 18 months. Ane likes “impossible” challenges both in the professional and private life. She biked from Oslo to Rome in 21 days (2940 km), runs half-marathon in 1h42 minutes and explore the wild back-countries of Norway, Australia, Alaska on auto sufficiency over several weeks.
Joel Järvinen (UBER)
Daniel Thurley (Roche)
Dr Thurley is the General Manager for Roche Pharmaceuticals in Hong Kong and Macau.
Reporting into the regional office for Roche in Asia in Singapore, Daniel is responsible for all aspects of commercial operations and R&D since 2018. Previously Daniel was the General Manager for Roche Pharmaceuticals in New Zealand, and before that, for over a decade, was Medical Director in Australia, UK, Singapore and Switzerland in local, regional and global roles.
Daniel is a United Kingdom trained Consultant Physician (Cambridge University) who has practiced in several countries around the World, primarily in the field of Medical Oncology.
He is a Member of the Royal College of Physicians (Edinburgh), and is a Fellow of the Faculty of Pharmaceutical Medicine, and continues to be an examiner for the UK College. He is a Member of the American Society of Clinical Oncology (ASCO), and in Hong Kong, a member of the Board of Directors of the Hong Kong Association of the Pharmaceutical Industry (HKAPI).
Thomas Anglero (IBM)
Thomas is the Director of Innovation at IBM Norway and is renowned for his powerful and inspirational presentations on inspiration and innovation. In 2017, Thomas consulted with leaders throughout Europe in strategic business areas like Healthcare, Fashion, Public Sector, IT and Innovation.
Thomas has over 25 years of IT/Telecom experience, founded 2 startups, hosts the “Soul of Innovation” podcast, and is currently writing a book on artificial intelligence and creating an online course for executives to be a successful innovative leaders during this time of massive technological and cultural change.
Mr. Anglero is a Puerto Rican/American who has lived 20+ years in Norway. He is married with 3 athletic children. Thomas is a level-2 FIBA certified champion basketball coach with 10+ years of championship coaching experience.
Itedale Namro Redwan (Cellink)
Itedale holds a PhD degree in Chemistry with emphasis on Medicinal/Organic Chemistry from the University of Gothenburg. She obtained her Postdoctoral training in Chemical Biology at the Gladstone Institutes in San Francisco. She was an Assistant Professor at the Clinical Chemistry and Transfusion Medicine at the University of Gotehnburg prior to joining CELLINK as a Senior Principal Scientist/Scientific Officer. Itedale is cuttently leading the Bioink and Tissue Engineering R&D team. Presentation of the 3D bioprinter, technology and future potential of technology, such as the ability to 3D bioprint new living, tissue and organ models.
Mathias Goyen (GE Healthcare)
Prof. Dr. med. Mathias Goyen is currently the Chief Medical Officer Europe for GE Healthcare, a $19 billion division of General Electric. Mathias is responsible for leading GE Healthcare’s medical, clinical and evidence generation strategies for product modalities in Europe. Together with his team he provides leadership in healthcare economics and outcomes research and comparative effectiveness research to develop customer value propositions for new and existing products
Mathias began his career as a diagnostic Radiologist working at Essen and Hamburg/Germany. He was appointed Professor of Diagnostic Radiology at the University of Hamburg/Germany in 2010. Mathias’ previous experience also includes 5 years as Managing Director of UKE Consult and Management GmbH, a subsidiary of the University Medical Center Hamburg where he was responsible for the overall consulting and foreign business of the University Medical Center Hamburg. Together with the leadership team of the hospital Mathias established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies.
Mathias holds a medical degree from the University of Bochum, Germany. He has been secretary general of the German-Chinese Society of Medicine, Berlin, since 2005. Mathias lives in Essen/Germany with his family.
Steinar Thoresen (AbbVie)
Steinar Thoresen is medical director of the biopharmaceutical company AbbVie. He is a doctor with specialization in pathology and epidemiology and has taken a doctorate on breast cancer. He is former head of national cancer screening at the Cancer Registry and
Professor II at UiB 1999-2013.
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
Erik Velldal (UiO)
Erik Velldal is an associate professor at the Language Technology Group at the Department of Informatics, UiO. He has over 15 years of experience in applying machine learning for the analysis of text and human language.
Natural Language Processing (NLP) is a sub-field of AI concerned with enabling machines to `make sense’ of human language. An increasingly central application of NLP is so-called opinion mining or sentiment analysis. This is the task of automatically identifying the opinions, attitudes or emotions that are expressed by subjective information in text. In the SANT project we develop resources for fine-grained sentiment analysis for Norwegian, through the use of neural models / Deep Learning.
Berit Floor Lund (Kongsberg Maritime)
Making robust, advanced applications on real-time data harvested from technical systems pose many types of challenges and call for creative approaches and combinations of methods. The available data determine both which questions can be asked, and which methods are relevant in order to answer them. Berit Floor Lund has been Tech Lead for analytics for Renewables in Kongsberg Digital before joining Kongsberg Maritime, Subsea in 2018. She is currently about to start as Product Manager for Aquaculture systems in Kongsberg with Ocean Farm 1 as the most important installation. Before joining Kongsberg in 2012, Berit was a senior scientist and research manager in SINTEF. Her education is in cybernetics and control at NTNU with a MSc in 1987, and PhD in 2005.
Gunnveig Grødeland (UiO)
Gunnveig Grødeland (MSc/PhD) is senior scientist at the K.G. Jebsen Centre for Influenza Vaccine Research, Department of Immunology, University of Oslo and Oslo University Hospital. The main topic of her research has been development of novel vaccine formats against influenza, with a focus on rapid responses against pandemic threats. A research stay in 2017 as a Fulbright Scholar at Scripps Research Institute, San Diego, US, gave more insight into the mechanistic basis for broad protection against all influenza subtypes, and Grødeland is presently continuing the search for a vaccine that can prevent both seasonal and pandemic influenza.
Anne Catrine T. Martinsen (Imtech)
Head of Department of Diagnostic Physics, Oslo University Hospital
Associated Professor, Department of Physics, University in Oslo
Research group leader for CT technology and CT image optimization
Martinsen established, and has since been running, a regional physicist service in Norway in 2005, providing physicist services in nearly 40 radiological and nuclear medicine departments and private institutes in the South-Eastern Health region. 27 full time employed physicists are working in the section on regularly basis, covering the full range of imaging modalities and associated technologies; CT, X-ray, intervention and radiation protection , PET, SPECT and MRI . Nearly 30 PhD-students, post docs and researchers are affiliated the Department of Diagnostic Physics. In 2017, Martinsen initiated and established Oslo Imaging Technology Research and Innovation Centre (ImTECH): The evolution of the patient centric healthcare model requires better integrated diagnostic imaging into a multidisciplinary solution, and in parallel, is driving the demand for medical imaging equipment to have superior performance and expanded capabilities. The primary objective of ImTECH is to establish a vibrant and dynamic hubin a working hospital environment, where partners from the hospital, academic institutions and industry have access to state-of-the-art infrastructure for innovation, implementation and evaluation of the next generation diagnostic imaging technologies. ImTECH experts will give continuous input and feedback on technological improvements and future developments, educational needs, structured reporting and image protocol optimization and standardization
Ilangko Balasingham (NTNU)
Ilangko Balasingham received the M.Sc. and Ph.D. degrees from the Department of Electronic Systems, Norwegian University of Science and Technology (NTNU), Trondheim in 1993 and 1998, respectively, both in signal processing. He performed his Master’s degree thesis at the Department of Electrical and Computer Engineering, University of California Santa Barbara, USA. From 1998 to 2002, he worked as Research Engineer developing image and video streaming solutions for mobile handheld devices at Fast Search & Transfer ASA, Oslo, which is now part of Microsoft Inc. Since 2002 he has been with the Intervention Center, Oslo University Hospital, where he heads the Section for Medical ICT R&D. He was appointed as Professor of Medical Signal Processing and Communications at NTNU in 2006. For the academic year 2016/2017 he was Professor by courtesy at the Frontier Institute, Nagoya Institute of Technology in Japan. His research interests include super robust short range communications for both in-body and on-body sensors, body area sensor network, microwave short range sensing of vital signs, short range localization and tracking mobile sensors, and nanoscale communication networks. He has authored or co-authored over 230 journal and conference papers, 7 book chapters, 42 abstracts, 6 patents, and 20 articles in popular press.
Arnoldo Frigessi (UiO)
Will a treatment work for a cancer patient? Soon we will be able to test on a computer how the tumour in a patient will respond to a chosen treatment: will it shrink and disappear, as we hope, or will it remain or even grow? We will soon be able to simulate on a computer, during one night, how the one tumour of the one patient who has to be treated on the next morning, will change if exposed to thousands of alternative treatments.
Arnoldo Frigessi is professor of statistics at the University of Oslo, leads the Oslo Centre for Biostatistics and Epidemiology at UiO and OUS and is director of BigInsight, a Norwegian centre of excellence for research-based innovation. Together with a large team of scientists and students, he develops one of the first computer based system that allows simulating the response to treatment of individual cancer patients.
He exploits the power of computers; he designs mathematical models that describe how drugs work; he adapts these models to individual patient using statistics. And he runs millions of imaginary therapies exactly for this one patient.
Frigessi develops model based and machine learning methodologies for bigdata. His research has contributed to modern computationally intensive statistics. Currently, Frigessi beside cancer researchis also working on recommender systems, viral marketing, and electronic health records.
Marte Thuen (NordicNeuroLab)
Marte Thuen has a Master degree in Physics, and a PhD in Medical Technology, both from Norwegian University of Science and Technology, in Trondheim, Norway. After working as a Post doc at the university for some years, she joined NordicNeuroLab 7 years ago, as the Chief Technology Officer (CTO).
NordicNeuroLab (NNL) is a company that provides software and hardware solutions for functional MRI and advanced neuroanalysis. Their software applications includes modules such as BOLD fMRI, diffusion tractography, ASL, perfusion, resting state fMRI, and the hardware is MR safe products for providing stimuli during fMRI scans.
As CTO, she is responsible for future development decisions, product portfolio and roadmap planning. She is heavily involved in software development, defining workflows and content of the software applications, based on user inputs and needs.
Sunniva Rose holds a PhD in nuclear physics from the University of Oslo, where she studied thorium as a fuel in nuclear reactors. As a passionate science communicator, she works today full time as a public speaker and writer, and often appears on radio and TV. She also runs the podcast LØRN.TECH together with Silvija Seres, about hot topics in technology such as drones, blockchain and virtual reality, and how these change our society.
Atle Timenes (Wheel.me)
Atle Timenes er gründer og CEO i wheel.me, et norsk IoT-selskap som har utviklet verdens første autonome hjul. Atle startet sin gründertilværelse som 27-åring da han etablerte CRM as. To år senere solgte han selskapet til c.Rel (Kistefos). Siden har Atle jobbet med å utnytte teknologi innenfor mange ulike bransjer. Atle har en mastergrad fra BI, og er ellers å regne som autodidakt når det kommer til teknologi.
Leonardo A. Meza-Zepeda (Oslo University Hospital)
Meza-Zepeda studied Biochemistry in Chile, followed by doctoral studies at University of Oslo. He has developed his career at the Institute for Cancer Research at Oslo University Hospital. Currently he is the head of the Department of Core Facilities and leads the Translational Genomics group at the Institute for Cancer Research. His group aims to understand cancer genome biology, by studying the genetic and epigenetic events that control cancer development and progression. Meza-Zepeda has for many years studied the biology and genetics of sarcoma, malignant tumours of mesenchymal origin, identifying key regulatory mechanisms and pathways that play a role in sarcoma development and progression. His group also works establishing novel state-of-the-art methods for analysis of tumour samples, and is helping implement these new technologies into routine cancer diagnostics. Meza-Zepeda’s ultimate goal is to translate this knowledge to improve patient diagnosis, treatment and care.
Per Buer (Include OS)
Buer describes himself as a pretty nerdy guy who brews sour beer and creates useless contraptions that entertain the rest of his family.
Tore Teppan (Posten Norge)
Gunnar Inderberg (Posten Norge)
Geir Kjetil Sandve (UiO)
Every person has millions of immune cells that each recognize a different potential invader. What a given cell will recognize is determined by its receptor sequence – a relatively short nucleotide sequence generated by a highly random process. However, while the initial generation is random, only cells that actually recognize some molecule in our body will survive. Our immune cell repertoire thus represents a highly detailed historic account of our past and present disease states. While recent technological breakthroughs has made it feasible to read millions of immune receptor sequences from a blood sample, there is unfortunately no trivial way to determine which recognized molecules and diseases this corresponds to. Through machine learning we aim to learn the code of immune cell recognition, opening up an enormous potential for disease diagnostic and treatment.
Geir Kjetil Sandve is an associate professor in Biomedical Informatics at the University of Oslo. He has fifteen years of experience with the use of machine learning for discovering patterns in biological sequences, for detecting associations between genomic features, and most recently for learning what is recognized by a specific immune cell.
Anton Bolstad (Space Norway)
Anton is working as a System Engineer in the Innovation and Development department at Space Norway AS. In addition to working with narrowband maritime IoT he is also involved in development of a multi-gigabit downlink radio for a SAR satellite and regulatory affairs . Before coming to Space Norway Anton worked with regulatory affairs, both on a national and international level, at the Norwegian Communications Authority. Anton holds a MSc EE from the Norwegian University of Technology and Science.
Anders Gundersen (Sensonomic)
Anders Gundersenis the founder and CEO of Sensonomic. He holds an MBA from the University of Oxford, and a Master’s Degree in Economics from the University of Bergen. Whilst leading a consulting project in rural Kenya, in-between fending off hyenas and walking into elephants at night, he formed the idea of what was to eventually turn into Sensonomic.
Sensonomic is able to predict productivity and optimise logistics for global agriculture. Through new methodologies for data capture and computational simulations we show how humans, the environment and the economy interact. We are working with the United Nations, international agriculture businesses, and several nation states – work that has taken us from Mauritania to Fiji. At the core of all our work is the realisation that land management issues are incredibly complex – and that big data and computational simulations are a very good help in making the best possible decisions.
At Cutting Edge Anders will talk about how we optimise logistics for agricultural supply chains. We have proved that by optimising harvest capture and the first level of the logistics supply chain we can increase value capture from plantation agriculture by more than 10 % without negative sustainability implications.
Gard O Sundby Thomassen (UiO)
Tønnes Nygaard (UiO)
Johannes Solhusvik (OmniVision)
Johannes Solhusvik received his PhD in 1996 on CCD and CMOS Image Sensor (CIS) design at ISAE, Toulouse, France. After which he joined ABB (Norway). In ‘99 he established Photobit (Norway) CIS design center which became Micron (Norway) in ‘01. He expatriated during 2004-06 to Micron’s CIS HQ in USA, managing design teams in USA, Japan, UK and Norway. He then repatriated to focus on CIS R&D. In 2009 he joined the Micron spin-off, Aptina (Norway), where he served as Fellow and CTO of Automotive BU until ‘12 when he joined OmniVision (Norway) as General Manager with focus on product design and chip architecture. Dr. Solhusvik is IISS board member and TPC member, and has served as TPC member of ISSCC from ‘05 to ‘11, and of ESSCIRC from’11 until present. He has a 10% position as Associate Adjunct Professor at University of Oslo.
Brage W. Johansen (DesertControl)
Brage W. Johansen is a serial entrepreneur and has a Master of Science from Norwegian University of Science and Technology (NTNU). Currently CEO of Desert Control and Heimdal Power AS. Work experience from multi-billion corporations and start-ups, in the renewable energy, space, oil&gas and environment industries. Several board positions in start-up companies, funds and non-profit organisations. Engineer at heart, but numerous add-ons of philosophy, psychology, management and business. Born north of the Arctic Circle. Head of Norway’s first 24/7 Hydrogen station 2006-2011.
Producer of FYK – Norway’s only environment friendly sportscar. Cofounder of Space & Energy innovation network. Has a ticket for a spaceflight after national contest about “Building on Mars” by AF Group. Special interest in and holds lectures about Astronomy, Vikings and Innovation.
Eugene Liu (GE Healthcare)
Eugene leads Revolution CT portfolio, a $200M business at GE Healthcare. He has overall responsibility for new product strategy, engineering programs, customer collaboration and business performance.
His team has designed the breakthrough platform to converge the whole organ coverage, high definition, temporal resolution and spectral imaging, all in one system, and has achieved the innovative “firsts” such as unlimited 1-beat cardiac CT technology and volume spectral CT technology with a simplified workflow. Under his leadership, Revolution CT has become the best-selling ultra-premium CT in the world with ~500 global install base and ~50% global market share.
Eugene graduated with MD degree from Shandong University Medical School, and practiced radiology at China MOH Affiliated Beijing Hospital before joining GE.
Kamran Shalchian-Tabrizi (UiO)
Petter Risholm (SINTEF)
3D machine vision has been one of key enablers behind self-driving cars and industrial automation. We present cutting-edge 3D sensors designed for the underwater environment that we expect will enable the same level of autonomy in the fishing industry and subsea factories.
Petter Risholm is a senior researcher at SINTEF Smart Sensor Systems. Expertise in machine vision.
Atle Bjørnerud (OUS)
Head of MR Physics and Analysis research group
Department of Diagnostic Physics, Division of Radiology and Nuclear Medicine, Oslo University Hospital
Department of Physics, Faculty of Mathematics and Natural Sciences, University of Oslo
Dag Undlien (UiO)
Anders Fugelli (Pharmasum Therapeutics)
Morten Isaksen (Bio-Me)
Dr. Isaksen earned his doctorate in Biotechnology from the University of Oslo in 1993. As part of his doctorate, he was visiting scholar at UC Berkeley from 1990 – 1991, and at The European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany in the fall of 1991. He has since had extensive experience with commercial biotech; established and run several biotech companies in Norway and the UK, and has acted as consultant for many others. He is the Founder and CEO of Bio-Me, which was established in 2016. Bio-Me offers revolutionary new technology to analyse the gut microbiome in relation to health and disease.
Bio-Me build the technological platform required to revolutionise our medical understanding of who we are and the fundamental mechanics of health and disease. By transforming how microbiome analysis is done, we surpass the thresholds required to investigate and recover the promise of precision medicine, personalised nutrition and a whole new class of therapeutics and drugs centred around a functional understanding of the microbiome.
Trine Hvoslef-Eide (NMBU)
As a professor in Applied Plant Biotechnology Trine Hvoslef-Eide participates in the public debate, particularly on GMO and gene editing, both as letters to the major newspapers and through lectures and panel debates. She teaches a range of plant biotechnology classes at NMBU, both practical courses in the lab and in more theory through her course on Case Studies of GMO. Here the students benefit from her time as an advisor on the Gene Technology Act in the Ministry of Environment in 1993-94. Through her many collaborate projects, she has been actively involved in mass propagation through cell- and tissue culture, cleaning virus infected plants through shoot tip culture, production of bioactive compounds from GM cells in bioreactors, genetic transformation, mutation breeding and gene editing. She uses biotechnology tools also in the studies of plant development.
She is leading the work on gene editing of potato within the industry lead GENEinnovate project on gene editing of important organisms for Norway, namely cattle, pigs, salmon and potato.
Professor Hvoslef-Eide is a supervisor for several master and PhD students from around the world.
Armend Gazmeno Håti (AkerBioMarine)
Armend Håti is a Director of Product & Technology within the Product Development Team at Aker BioMarine; a global krill fishery leader recently awarded Europe’s Most Innovative Company by European Business Awards.
Armend holds an MSc in Applied Physics and Mathematics and a PhD in Biophysics from The Norwegian University of Science and Technology. During his PhD, he contributed to advancements in the field of lab-on-chip technology and tissue engineering and his findings are currently being explored in the tailor-making of biomimetic materials and organ printing. Armend has spent time at world leading lab-on-chip laboratories at Harvard University and EPFL as part of his PhD education and worked as an Industrial Postdoc at EPFL prior to joining the Aker BioMarine Product Development Team.
Morten Sollerud (Norilia)
Marius Holm (Zero Norway)
Monica Larsen (Legemiddelindustrien)
Odd Magne Rødseth (EW Group GmbH)
Ellen Cathrine Rasmussen (Yara)
Knut Korsell (UiO)
Espen Davidsen (Intelecy)
Espen is COO and Co-Founder at Intelecy. Intelecy is determined to make industrial production cleaner, safer and more effective. Espen Davidsen is both an engineer and a strategic leader with more than 15 years of experience building technology and companies. He works best in the intersection between strategy, technology and operations. As the COO at Intelecy his focus is to build a strong team and ensure rapid international growth.
EMBA in Strategic Management from Norwegian School of Economics (NHH)
Master in Computing Science from UK
Ole-Johan Skrede (UiO)
At ICGI we use informatics to study genetic alterations in order to establish new and better methods for diagnosis and prognosis of different cancers. Many of our methods are based on analysis of microscope images of cancer tissue, and is therefore closely related to pathology and histology. In silico refers to our use of digital image analysis, which means that the analysis is done automatically by computers.
Machine learning, and especially deep learning with neural networks, has during the last couple of years been established as the best method for solving high-level computer vision tasks. This talk will present some applications of deep learning at our institute.
Jon Olav Vik (NMBU)
Jon Olav Vik leads the “Digital Salmon” research project, which is about systems biology for salmon farming. View the Digital Salmon animated film!
The project is funded by the Research Council of Norway, grant 248792.
An ecologist with a liking for math and computers, Vik has studied biological phenomena ranging from cannibalism in trout, to climate effects on population dynamics, to the impact of genetic variation in simulation models of the heartbeat. He is currently a researcher at the Norwegian University of Life Sciences, which is the node for digital production biology within the national consortium for biotechnology, Centre for Digital Life Norway(RCN grant 248810).